Optimizing global risk evaluation in primary hypertension: The role of microalbuminuria and cardiovascular ultrasonography

Journal of Hypertension

Volumn 22, Issue 5, 2004, Pages 907-913

  Viazzi, Francesca ^a   Parodi, Denise ^a   Leoncini, Giovanna ^a   Vettoretti, Simone ^a   Ratto, Elena ^a   Vaccaro, Valentina ^a   Ravera, Maura ^a   Tomolillo, Cinzia ^a   Bezante, Gian Paolo ^a   Del Sette, Massimo ^b   Deferrari, Giacomo ^a   Pontremoli, Roberto ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

Cardiovascular risk; Carotid atherosclerosis; Cost effectiveness; Hypertension; Left ventricular hypertrophy; Microalbuminuria; Target organ damage

Indexed keywords

ADULT; ARTERY INTIMA; ARTERY MEDIA; ARTICLE; CARDIOVASCULAR RISK; CAROTID ARTERY; COST EFFECTIVENESS ANALYSIS; ECHOCARDIOGRAPHY; ECHOGRAPHY; FEMALE; HEART LEFT VENTRICLE MASS; HEART VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; INTIMA; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; PRIORITY JOURNAL; PROTEINURIA; RISK ASSESSMENT; SENSITIVITY ANALYSIS; STATISTICAL SIGNIFICANCE; TARGET ORGAN; URINALYSIS;

EID: 2542418335     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200405000-00011     Document Type: Article

References (22)

1. Ogden LG, He J, Lydick E, Whelton PK. Long-term absolute benefit of lowering blood pressure in hypertensive patients according to the JNC VI risk stratification. Hypertension 2000; 35:539-543.
2. Zanchetti A, Hansson L, Dahlöf B, Elmfeldt D, Kjeldsen S, Kolloch R, et al. Effects of individual risk factors on the incidence of cardiovascular events in the treated hypertensive patients of the Hypertension Optimal Treatment Study. J Hypertens 2001; 19:1149-1159.
3. Guidelines Committee. 2003 European Society of Hypertension - European Society of Cardiology guidelines for management of arterial hypertension. J Hypertens 2003; 21:1011-1053.
4. Leoncini G, Sacchi G, Viazzi F, Ravera M, Parodi D, Ratto E, et al. Microalbuminuria identifies global cardiovascular risk in essential hypertension: an artificial neural network-based approach. J Hypertens 2002; 20:1315-1321.
5. Cuspidi C, Ambrosioni E, Mancia G, Pessina AC, Trimarco B, Zanchetti A. Role of echocardiography and carotid ultrasonography in stratifying risk of patients with essential hypertension: the Assessment of Prognostic Risk Observational Survey. J Hypertens 2002; 20:1307-1310.
6. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC VII report. JAMA 2003; 289:2560-2572.
7. Jager A, Kostense PJ, Ruhe HG, Heine RJ, Nijpels G, Dekker JM, et al. Microalbuminuria and peripheral arterial disease are independent predictors of cardiovascular and all-cause mortality, especially among hypertensive subjects: five-year follow-up of the Hoorn Study. Arterioscler Thromb Vasc Biol 1999; 19:617-624.
8. Donnelly R, Rea R. Microalbuminuria: how informative and reliable are individual measurements? J Hypertens 2003; 21:1929-1933.
9. Pontremoli R, Sofia A, Ravera M, Nicolella C, Viazzi F, Tirotta A, et al. Prevalence and clinical correlates of microalbuminuria in essential hypertension: the MAGIC study. Hypertension 1997; 30:1135-1143.
10. Sokolow M, Lyon TP. The ventricular complex in left ventricular hypertrophy as obtained by unipolar precordial and limb reads. Am Heart J 1949; 37:161-186.
11. Molloy TJ, Okin PM, Devereux RB, Kligfield P. Electrocardiographic detection of left ventricular hypertrophy by the simple QRS voltage-duration product. J Am Coll Cardiol 1992; 20:1180-1186.
12. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, et al. Recommendations for quantitation of the left ventricle by two dimensional echocardiography: American Society of Echocardiography Committee on standards, subcommittee on quantitation of two-dimensional echocardiograms. J Am Soc Echocardiogr 1989; 2:358-367.
13. Weldelhag I, Wiklund O, Wikstrand J. Atherosclerotic changes in the femoral and carotid arteries in familial hypercholesterolemia: ultrasonographic assessment of intima-media thickness and plaque occurrence. Arterioscler Thromb 1993; 13:1404-1411.
14. Nielsen OW, McDonagh TA, Robb SD, Dargie HJ. Retrospective analysis of the cost-effectiveness of using plasma brain natriuretic peptide in screening for left ventricular systolic dysfunction in the general population. J Am Coll Cardiol 2003; 41:113-120.
15. Persson M, Carlberg B, Weinehall L, Nilsson L, Stegmayr B, Lindholm LH. Risk stratification by guidelines compared with risk assessment by risk equations applied to a MONICA sample. J Hypertens 2003; 21:1089-1095.
16. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelii WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990; 322:1561-1566.
17. Casale PN, Devereux RB, Milner M, Zullo G, Harshfield GA, Pickering TG, et al. Value of echocardiographic measurement of left ventricular mass in predicting cardiovascular morbid events in hypertensive men. Arch Intern Med 1986; 105:173-178.
18. Hodis HN, Mack WJ, Labree L, Selzer RH, Liu CR, Liu CH, Azen SP. The role of carotid arterial intima-media thickness in predicting clinical coronary events. Ann Intern Med 1998; 128:262-269.
19. O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK, for the Cardiovascular Health Study Collaboration Research Group. Carotid artery intima-media thickness as a risk factor for myocardial infarction and stroke in older adults. N Engl J Med 1999; 340:14-22.
20. Jensen JS, Feldt-Rasmussen B, Strandgaard S, Schroll M, Borch-Johnsen K. Arterial hypertension, microalbuminuria, and risk of ischemic heart disease. Hypertension 2000; 35:898-903.
21. Hillege HL, Fidler V, Diercks GF, van Gilst WH, de Zeeuw D, van Veldhuisen DJ, et al. Prevention of Renal and Vascular End Stage Disease (PREVEND) Study Group. Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation 2002; 106:1777-1782.
22. Wolf-Maier K, Cooper RS, Banegas JR, Giampaoli S, Hense HW, Joffres M, et al. Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA 2003; 289:2363-2369.